A novel approach to reverse Warburg metabolism in patients with recurrent glioblastoma: A phase II pharmacodynamic study of dichloroacetate

Authors
Category Primary study
JournalNeuroOncol. Adv.
Year 2026
This article has no abstract
Epistemonikos ID: 83626867b043ecad593cf06a083aa61e6103b5ab
First added on: Oct 03, 2026